S&P 500   4,467.71
DOW   35,123.36
QQQ   367.91
2 Tech Stocks to Buy and One to Avoid in August
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Stocks to Buy No Matter Which Way Inflation Moves
3 Stocks to Buy After Heavy Insider Buying
Ben Stein FREE Report: How Americans Are RUINING Retirement (Ad)
2 Alternatives To Tesla (1 Safe, 1 More Risky)
The Rivian Market Is About To Shift Into A Higher Gear 
Ben Stein FREE Report: How Americans Are RUINING Retirement (Ad)
7 Best Fintech ETFs to Buy Now
How major US stock indexes fared Wednesday, 8/9/2023
S&P 500   4,467.71
DOW   35,123.36
QQQ   367.91
2 Tech Stocks to Buy and One to Avoid in August
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Stocks to Buy No Matter Which Way Inflation Moves
3 Stocks to Buy After Heavy Insider Buying
Ben Stein FREE Report: How Americans Are RUINING Retirement (Ad)
2 Alternatives To Tesla (1 Safe, 1 More Risky)
The Rivian Market Is About To Shift Into A Higher Gear 
Ben Stein FREE Report: How Americans Are RUINING Retirement (Ad)
7 Best Fintech ETFs to Buy Now
How major US stock indexes fared Wednesday, 8/9/2023
S&P 500   4,467.71
DOW   35,123.36
QQQ   367.91
2 Tech Stocks to Buy and One to Avoid in August
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Stocks to Buy No Matter Which Way Inflation Moves
3 Stocks to Buy After Heavy Insider Buying
Ben Stein FREE Report: How Americans Are RUINING Retirement (Ad)
2 Alternatives To Tesla (1 Safe, 1 More Risky)
The Rivian Market Is About To Shift Into A Higher Gear 
Ben Stein FREE Report: How Americans Are RUINING Retirement (Ad)
7 Best Fintech ETFs to Buy Now
How major US stock indexes fared Wednesday, 8/9/2023
S&P 500   4,467.71
DOW   35,123.36
QQQ   367.91
2 Tech Stocks to Buy and One to Avoid in August
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Stocks to Buy No Matter Which Way Inflation Moves
3 Stocks to Buy After Heavy Insider Buying
Ben Stein FREE Report: How Americans Are RUINING Retirement (Ad)
2 Alternatives To Tesla (1 Safe, 1 More Risky)
The Rivian Market Is About To Shift Into A Higher Gear 
Ben Stein FREE Report: How Americans Are RUINING Retirement (Ad)
7 Best Fintech ETFs to Buy Now
How major US stock indexes fared Wednesday, 8/9/2023
NASDAQ:TNGX

Tango Therapeutics (TNGX) Earnings Date, Estimates & Call Transcripts

$7.81
+3.98 (+103.92%)
(As of 08/9/2023 ET)
Compare
Today's Range
$5.00
$9.39
50-Day Range
$2.67
$7.81
52-Week Range
$2.47
$9.39
Volume
74.84 million shs
Average Volume
694,361 shs
Market Capitalization
$690.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.00

Earnings Summary

Upcoming
Earnings Date
Nov. 9Estimated
Actual EPS
(Aug. 7)
-$0.23 Beat By $0.10
Consensus EPS
(Aug. 7)
-$0.33
Skip Charts & View Estimated and Actual Earnings Data

TNGX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TNGX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Tango Therapeutics Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20233($0.37)($0.34)($0.36)
Q2 20233($0.39)($0.32)($0.35)
Q3 20233($0.41)($0.33)($0.36)
Q4 20233($0.43)($0.31)($0.37)
FY 202312($1.60)($1.30)($1.43)
Q1 20241($0.38)($0.38)($0.38)
Q2 20241($0.32)($0.32)($0.32)
Q3 20241($0.34)($0.34)($0.34)
Q4 20241($0.35)($0.35)($0.35)
FY 20244($1.39)($1.39)($1.39)

TNGX Earnings Date and Information

Tango Therapeutics last released its quarterly earnings results on August 7th, 2023. The reported ($0.23) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.33) by $0.10. The company earned $14.60 million during the quarter, compared to analysts' expectations of $7 million. Tango Therapeutics has generated ($1.21) earnings per share over the last year (($1.21) diluted earnings per share). Earnings for Tango Therapeutics are expected to grow in the coming year, from ($1.40) to ($1.25) per share. Tango Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 9th, 2023 based off prior year's report dates.

Tango Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/9/2023
Estimated)
------- 
8/7/2023Q2 2023($0.33)($0.23)+$0.10($0.23)$7.00 million$14.60 million
5/9/2023Q1 2023($0.36)($0.32)+$0.04($0.32)$6.70 million$5.77 million
3/27/2023Q4 2022($0.36)($0.33)+$0.03($0.33)$6.60 million$6.41 million
11/10/2022Q3 2022($0.32)($0.33)($0.01)($0.33)$5.97 million$6.92 million
8/10/2022Q2 2022($0.33)($0.28)+$0.05($0.28)$5.97 million$5.77 million
5/11/2022Q1 2022($0.28)($0.29)($0.01)($0.29)$6.31 million$5.76 million
3/28/2022Q4 2021($0.28)($0.25)+$0.03($0.25)$6.12 million$5.72 million
11/9/2021Q3 2021($0.26)($0.28)($0.02)($0.28)$6.11 million$6.79 million












Tango Therapeutics Earnings - Frequently Asked Questions

When is Tango Therapeutics's earnings date?

Tango Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 9th, 2023 based off last year's report dates. Learn more on TNGX's earnings history.

Did Tango Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Tango Therapeutics (NASDAQ:TNGX) reported ($0.23) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.33) by $0.10. Learn more on analysts' earnings estimate vs. TNGX's actual earnings.

How much revenue does Tango Therapeutics generate each year?

Tango Therapeutics (NASDAQ:TNGX) has a recorded annual revenue of $24.86 million.

How much profit does Tango Therapeutics generate each year?

Tango Therapeutics (NASDAQ:TNGX) has a recorded net income of -$108.18 million. TNGX has generated -$1.21 earnings per share over the last four quarters.

What is Tango Therapeutics's EPS forecast for next year?

Tango Therapeutics's earnings are expected to grow from ($1.40) per share to ($1.25) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:TNGX) was last updated on 8/10/2023 by MarketBeat.com Staff

My Account -